UK consumers reduced their purchases of food and alcohol during the recent holiday season, a trend attributed to the growing popularity of weight loss injections. Grocery sales reached £19.6 billion in the four weeks leading up to December 27, showing a 2.5% increase compared to the previous year, according to data from NielsenIQ. However, sales volume experienced a slight decline of 0.2%.
Analysts in the retail sector suggest that the decline in food and alcohol sales is linked to the rising use of GLP-1 injections, which emulate a hormone that triggers a sense of fullness in the body. The National Health Service (NHS) prescribes weight loss injections like Mounjaro and Wegovy, as well as Ozempic for diabetes. Recent research estimates that approximately 1.6 million adults in the UK have utilized these injections within the past year.
Experts in the field, such as Jonathan De Mello from JDM Retail, highlight the “Ozempic effect” as a noticeable phenomenon impacting grocery sales, with an increase in GLP-1 usage leading to a year-on-year decline in food consumption among users. This trend has particularly affected high-calorie categories like snacks and alcohol. As a result, retailers are advised to adjust their product offerings to cater to the shift towards “less but better” consumption patterns.
Clive Black, a consumer analyst at Shore Capital, emphasized the impact of glucagon-peptide (GLP) drugs on eating habits, noting the decrease in the volume of groceries sold during the festive season. Major retailers have responded to this trend by introducing smaller meal options. For instance, Co-op launched a range of “mini meals” tailored for individuals with smaller appetites, while Marks & Spencer introduced a new “nutrient dense” product line, and Iceland expanded its frozen meal selection with 38 new options.
The influence of weight loss injections on consumer behavior is also evident in the statements made by industry leaders. The CEO of Greggs acknowledged the impact of such medications on their business performance, highlighting a shift towards smaller portions and increased demand for specific nutrients like protein and fiber. Tesco’s chief executive and Sainsbury’s CEO expressed vigilance in monitoring consumer trends, especially in light of the growing use of weight loss medication.
The evolving landscape of consumer preferences and health consciousness is prompting retailers to adapt their offerings to meet the changing demands of the market.